ALHC
HealthcareAlignment Healthcare, Inc. · Medical - Healthcare Plans · $3B
What is Alignment Healthcare, Inc.?
Alignment Healthcare is a tech-enabled Medicare Advantage company focused on delivering consumer-centric care to seniors across select U.S. markets. Its platform coordinates health services through owned and affiliated Medicare Advantage plans.
Alignment Healthcare operates Medicare Advantage health plans in California, North Carolina, and Nevada. It uses a proprietary technology platform to coordinate professional, institutional, and ancillary health services for enrolled members. The company also partners with unaffiliated Medicare Advantage HMOs to provide covered services to their members. Revenue is generated primarily through capitated payments tied to member enrollment in its health plans.
The company was founded in 2013 and is headquartered in Orange, California.
- Owned Medicare Advantage health plans in three states
- Tech-enabled care coordination platform for seniors
- Ancillary and institutional health service coordination
- Partnerships with unaffiliated Medicare Advantage HMOs
Is ALHC a Good Stock to Buy?
UQS Score rates ALHC as Below Average overall.
The standout pillar for Alignment Healthcare is Growth, which ranks among the stronger readings in the sector — reflecting the company's rapid membership expansion and the broader tailwind of an aging U.S. population enrolling in Medicare Advantage. Risk comes in at a Neutral reading, suggesting the company's exposure profile is neither alarming nor particularly reassuring relative to peers.
Quality and Moat both register as Weak, pointing to ongoing profitability challenges and a limited competitive differentiation that could make sustained outperformance difficult. Valuation is flagged as Elevated, meaning the current price already reflects considerable optimism.
See the exact pillar breakdown and full financial metrics by signing up for a UQS Pro account. Sign up free →
Past performance does not guarantee future results. UQS Score is based on fundamental data and is not a buy/sell recommendation.
Does ALHC pay dividends?
No — Alignment Healthcare, Inc. does not currently pay a dividend.
Alignment Healthcare does not currently pay a dividend. As a growth-stage Medicare Advantage company still working toward consistent profitability, capital is directed toward expanding membership, building out its technology platform, and entering new markets rather than returning cash to shareholders.
When does ALHC report earnings?
Alignment Healthcare reports earnings on a quarterly cadence, consistent with standard practice for U.S.-listed equities.
The company has demonstrated meaningful membership growth in recent periods, though profitability metrics remain under pressure — a pattern common among tech-enabled insurers still scaling their platforms. Investors tend to focus on membership trajectory and medical cost ratios when evaluating quarterly results.
For the most recent quarter's results and guidance, visit Alignment Healthcare's investor relations page directly.
ALHC Price History
-14.5% over 5Y
Monthly close, adjusted for stock splits and dividend reinvestment.
What if I invested in Alignment Healthcare, Inc.?
Based on Alignment Healthcare, Inc.'s historical closing prices, adjusted for stock splits and dividend reinvestment. Past performance does not guarantee future results. This is for informational purposes only and is not financial advice.
ALHC Long-term Outlook
The fundamental outlook for Alignment Healthcare is shaped by a strong Growth pillar set against Weak Quality and Moat readings. The Medicare Advantage market continues to expand as the U.S. senior population grows, which supports membership gains. However, the path to durable profitability remains uncertain, and an Elevated Valuation pillar suggests the market has already priced in a favorable scenario — leaving limited room for execution missteps.
Growth drivers
- Aging U.S. population driving Medicare Advantage enrollment growth
- Geographic expansion into new states beyond current three-state footprint
- Technology platform efficiencies that could improve care coordination at scale
Key risks
- Persistent profitability pressure given Weak Quality and Moat pillar readings
- Elevated valuation leaves little margin of safety if growth slows
- Regulatory and reimbursement changes in the Medicare Advantage market
ALHC vs Peers
Alignment Healthcare competes in the tech-enabled and managed Medicare Advantage space alongside several other insurers targeting similar demographics.
Oscar Health targets a broader individual and small-group market using technology-first plan design, whereas ALHC focuses specifically on the senior Medicare Advantage population.
Molina operates at a larger scale across Medicaid and Medicare markets, offering a more diversified government-program revenue base compared to ALHC's Medicare Advantage focus.
Clover Health similarly targets Medicare Advantage with a data-driven approach but pursues a different geographic and provider-partnership strategy than Alignment Healthcare.
Frequently Asked Questions
What does Alignment Healthcare do?
Alignment Healthcare operates tech-enabled Medicare Advantage health plans for seniors in California, North Carolina, and Nevada. It uses a proprietary platform to coordinate medical, institutional, and ancillary services for enrolled members, and also partners with unaffiliated Medicare Advantage HMOs to provide covered services.
Does ALHC pay dividends?
No, Alignment Healthcare does not currently pay a dividend. The company is in a growth phase and reinvests available capital into membership expansion and platform development rather than distributing cash to shareholders.
When does ALHC report earnings?
Alignment Healthcare follows a standard quarterly earnings cadence for U.S.-listed companies. For precise dates and the latest results, check the investor relations section of the company's official website.
Is ALHC a good stock to buy?
UQS Score rates ALHC as Below Average overall. While the Growth pillar is Strong, the Quality and Moat pillars are both Weak, and Valuation is Elevated. That combination warrants careful consideration. The complete pillar breakdown is available to UQS Pro members.
Is ALHC overvalued?
The UQS Valuation pillar for ALHC is rated Elevated, suggesting the current market price reflects a high degree of growth optimism. Investors should weigh that against the Weak Quality and Moat readings before drawing conclusions.
How does ALHC compare to its competitors?
Compared to peers like Oscar Health, Molina Healthcare, and Clover Health, Alignment Healthcare is more narrowly focused on the senior Medicare Advantage segment. Its tech-enabled care coordination model differentiates it operationally, though its Quality and Moat scores currently lag what larger managed-care peers can demonstrate.
What is ALHC's market cap bracket?
Alignment Healthcare is classified as a mid-cap company. This places it in a segment of the market that can offer growth potential but may carry more volatility than large- or mega-cap healthcare peers.
Who founded Alignment Healthcare?
Alignment Healthcare was founded in 2013. For detailed information on its founding team and corporate history, the company's official website and public filings are the most reliable sources.
Is ALHC a long-term quality indicator?
From a long-term quality perspective, ALHC's Weak Quality and Moat pillar ratings suggest the business has not yet established the durable competitive advantages or consistent profitability that typically characterize high-quality long-term holdings. The Strong Growth pillar is a positive signal, but sustainability remains the key question.
What is the main competitive advantage of Alignment Healthcare?
Alignment Healthcare's primary differentiator is its proprietary technology platform, which is designed to coordinate care more efficiently for seniors enrolled in Medicare Advantage plans. However, the UQS Moat pillar currently rates this advantage as Weak, indicating it has not yet translated into a clearly defensible market position.
Is ALHC a growth stock or value stock?
Based on UQS pillar labels, ALHC leans toward the growth category — its Growth pillar is rated Strong while its Valuation pillar is Elevated, a combination more typical of growth-oriented names than value plays.
Unlock Full ALHC Analysis
Sign in to unlock the detailed analysis behind the UQS Score.
- ✓View the exact UQS Score and all five pillar ratings
- ✓Access full financial metrics and trend data
- ✓Compare ALHC against sector peers side by side
- ✓See the complete Quality and Moat deep-dive
- ✓Get the full Valuation context behind the Elevated rating
Pro Analysis
ALHC — Score History
| Date | UQS | Quality | Moat | Growth | Risk | Value | Change |
|---|---|---|---|---|---|---|---|
| May 22, 2026 | 49.8 | 43.7 | 25.0 | 100.0 | 54.3 | 29.9 | +0.1 |
| May 21, 2026 | 49.7 | 43.7 | 25.0 | 100.0 | 54.3 | 29.3 | -0.1 |
| May 20, 2026 | 49.8 | 43.7 | 25.0 | 100.0 | 54.3 | 29.9 | -0.2 |
| May 19, 2026 | 50.0 | 44.3 | 25.0 | 100.0 | 54.3 | 30.0 | -0.1 |
| May 16, 2026 | 50.1 | 44.3 | 25.0 | 100.0 | 54.3 | 31.1 | +0.7 |
| May 15, 2026 | 49.4 | 42.2 | 25.0 | 100.0 | 54.3 | 29.5 | +0.5 |
| May 14, 2026 | 48.9 | 42.2 | 25.0 | 100.0 | 54.3 | 26.4 | -0.2 |
| May 13, 2026 | 49.1 | 43.0 | 25.0 | 100.0 | 54.3 | 26.2 | -0.3 |
| May 12, 2026 | 49.4 | 43.0 | 25.0 | 100.0 | 54.3 | 28.4 | +0.4 |
| May 11, 2026 | 49.0 | 42.4 | 25.0 | 100.0 | 54.3 | 26.6 | +4.8 |
ALHC — Pillar Breakdown
Quality
— 43.7/100 (25%)Alignment Healthcare, Inc. has average quality metrics, with room for improvement in margins or capital efficiency.
How effectively capital is deployed to generate returns.
Profitability relative to shareholders' equity.
Ability to convert revenue into operating profit.
Bottom-line profit as a share of revenue.
Asset productivity — how much gross profit each dollar of assets generates.
Free cash flow relative to market value.
Growth
— 100.0/100 (20%)Alignment Healthcare, Inc. is growing rapidly with strong revenue and earnings expansion.
Revenue trajectory over the last twelve months.
Compound annual revenue growth rate over 3 years.
Year-over-year earnings per share growth.
Analyst consensus for future revenue growth.
Risk
— 54.3/100 (15%)Alignment Healthcare, Inc. has some risk factors including moderate leverage or solvency concerns.
Debt levels relative to earnings capacity.
Total debt relative to shareholder equity.
Short-term liquidity — ability to pay near-term obligations.
Earnings capacity relative to interest payments.
Valuation
— 29.9/100 (15%)Alignment Healthcare, Inc. appears expensively valued relative to its fundamentals and growth prospects.
Inverse of forward P/E — higher yield means cheaper stock.
How many years of FCF the market cap represents.
Enterprise value multiple relative to sector median.
Moat
— 25/100 (25%)Alignment Healthcare, Inc. operates in a highly competitive environment with limited sustainable advantages. The Moat pillar evaluates competitive advantages across five dimensions: Switching Costs, Network Effects, Cost Advantage, Intangible Assets, and Scale & Ecosystem. Sign in to customize moat ratings for ALHC.
Score Composition
Financial Data
More Stock Analysis
How is the ALHC UQS Score Calculated?
The UQS (Unified Quality Score) for Alignment Healthcare, Inc. is calculated using a proprietary 6-pillar framework with 29 financial metrics. Each pillar evaluates a different dimension on a 0–100 scale, then combines into a single weighted score. Scoring thresholds are calibrated per sector. Momentum is an optional Pro toggle — without it, you get the 5-pillar / 25-metric core shown below.
Quality (25%) measures profitability and capital efficiency — ROIC, ROE, margins, GP/Assets, and FCF Yield.
Moat (25%) assesses Alignment Healthcare, Inc.'s competitive advantages across switching costs, network effects, cost advantages, intangible assets, and ecosystem scale.
Growth (20%) tracks revenue trajectory and earnings momentum, combining historical results with analyst forward estimates.
Risk (15%) is inversely scored — lower leverage and strong balance sheet health result in higher scores.
Valuation (15%) measures whether Alignment Healthcare, Inc. is fairly priced using earnings yield, price-to-FCF, PEG ratio, and EV/EBITDA relative to sector peers.
Six investor-inspired presets are available, each with different pillar weights: Balanced, Buffett, Munger, Lynch, Cathie Wood, and Graham. The public score shown here uses the Balanced preset. Learn more in our FAQ.